← SynDRA
NS-018
SynDRA canonical compound SYN0039850 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | JAK1 | JAK2 | JAK3 | TYK2 |
| Mechanism of action | JAK inhibitor |
All known targets
Mechanisms of action (all sources)
- JAK2 INHIBITOR
- Tyrosine-protein kinase JAK2 inhibitor
- JAK inhibitor
- JAK2 MODULATOR
Cross-references
Synonyms
- Ilginatinib
- ilginatinib
- UNII-56R994WX4L
- 56R994WX4L
- GTPL7839
- SCHEMBL14954406
- UQTPDWDAYHAZNT-AWEZNQCLSA-N
- NS018
- ZINC68245917
- HY-19631A
- AKOS030526348
- DB12784
- CS-5358
- SB16921
- 2,6-Pyridinediamine, N2-((1S)-1-(4-fluorophenyl)ethyl)-4-(1-methyl-1H-pyrazol-4-yl)-N6-2-pyrazinyl-
- (S)-N2-[1-(4-fluorophenyl)ethyl]-4-(1-methyl-1H-pyrazol-4-yl)-N6-(pyrazin-2yl)pyridine-2,6-diamine
- (S)-N-(1-(4-Fluorophenyl)ethyl)-4-(1-methyl-1H-pyrazol-4-yl)-N'-(pyrazin-2-yl)pyridine-2,6-diamine
- ilginatinibum
- RefChem:1092193
- DTXCID801547275
- ILGINATINIB [INN]
- orb1309316
- SCHEMBL30007719
- BDBM50595922
- EX-A10357
- MS-26478
- NS00072915
- F85341
- T12266
- BRD-K21865955-003-01-5
- s59
- SCHEMBL30925296
- MS-29388
- EEC79987
- HY-19631
- orb1309315
- ns-018 maleate
Look up NS-018 in the interactive SynDRA portal →